{"filing":{"accession_number":"0001628280-26-059699","cik":"0002062583","ticker":"MMED","company_name":"MiniMed Group, Inc.","form":"8-K","filing_date":"2026-09-01","report_date":"2026-09-01","primary_document":"mmed-20260901.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/mmed-20260901.htm"},"events":[{"id":30761,"run_id":28200,"accession_number":"0001628280-26-059699","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"MiniMed issued a press release on September 1, 2026, announcing Q1 fiscal year 2027 financial results ended July 31, 2026, with net sales of $843 million (16.6% reported growth, 15.8% organic) and operating income of $5 million, while raising full-year organic revenue growth guidance to approximately 10.5%.","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-09-01","form":"8-K","submitted_at":null,"items":[{"id":33466,"accession_number":"0001628280-26-059699","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"MiniMed issued a press release on September 1, 2026, announcing financial results for Q1 fiscal year 2027 ended July 31, 2026, disclosing net sales of $843 million (16.6% reported growth, 15.8% organic), operating income of $5 million, and raising full-year organic revenue growth guidance to approximately 10.5%. The press release is attached as Exhibit 99.1 and includes condensed consolidated statements of operations and detailed revenue breakdowns, which is the standard format for an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T10:51:42.737237+00:00","company_name":"","ticker":null,"filing_date":""},{"id":33467,"accession_number":"0001628280-26-059699","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 incorporates by reference the information set forth under Item 2.02, which discloses MiniMed's Q1 FY2027 earnings results. The attached press release (EX-99.1) reports net sales of $843 million (16.6% reported growth, 15.8% organic), raised FY27 organic revenue guidance to ~10.5%, and includes detailed financial statements and segment performance. This is a standard earnings release disclosure material to investors assessing the company's financial performance and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T10:51:42.737237+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33466,"accession_number":"0001628280-26-059699","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"MiniMed issued a press release on September 1, 2026, announcing financial results for Q1 fiscal year 2027 ended July 31, 2026, disclosing net sales of $843 million (16.6% reported growth, 15.8% organic), operating income of $5 million, and raising full-year organic revenue growth guidance to approximately 10.5%. The press release is attached as Exhibit 99.1 and includes condensed consolidated statements of operations and detailed revenue breakdowns, which is the standard format for an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T10:51:42.737237+00:00","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-09-01"},{"id":33467,"accession_number":"0001628280-26-059699","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 incorporates by reference the information set forth under Item 2.02, which discloses MiniMed's Q1 FY2027 earnings results. The attached press release (EX-99.1) reports net sales of $843 million (16.6% reported growth, 15.8% organic), raised FY27 organic revenue guidance to ~10.5%, and includes detailed financial statements and segment performance. This is a standard earnings release disclosure material to investors assessing the company's financial performance and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T10:51:42.737237+00:00","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-09-01"}]}